Table 1.
Incidence by age and sex per 100 000 person-years
| Sex | Age | Total | |||
| 26–35 | 36–45 | 46–55 | 56–64 | ||
| VTE (DVT OR PE) | |||||
| Female | 95.26* | 161.16* | 235.13 | 374.65 | 224.14 |
| Male | 51.31 | 105.99 | 221.53 | 416.33 | 203.74 |
| Total | 72.43 | 132.87 | 228.27 | 395.31 | 213.79 |
| VTE+a (DVT+a OR PE+a) | |||||
| Female | 51.68* | 90.02* | 130.21 | 214.42 | 126.03 |
| Male | 29.78 | 65.90 | 143.87 | 276.78 | 132.56 |
| Total | 40.31 | 77.66 | 137.10 | 245.32 | 129.34 |
| CVT | |||||
| Female | 8.61 | 8.93 | 8.07 | 8.25 | 8.45 |
| Male | 2.54 | 2.70 | 4.52 | 7.39 | 4.36 |
| Total | 5.46 | 5.74 | 6.28 | 7.82 | 6.37 |
| Any major venous thrombosis (DVT, CVT and other)† | |||||
| Female | 113.72 | 187.86 | 272.82 | 426.94 | 258.85 |
| Male | 61.13 | 123.55 | 255.92 | 485.99 | 237.27 |
| Total | 86.40 | 154.87 | 264.29 | 456.20 | 247.89 |
| ITP | |||||
| Female | 30.38 | 27.09 | 27.80 | 38.23 | 30.99 |
| Male | 9.73 | 13.06 | 20.77 | 39.97 | 21.29 |
| Total | 19.66 | 19.90 | 24.25 | 39.09 | 26.06 |
| HUS | |||||
| Female | 0.96 | 1.08 | 1.38 | 1.51 | 1.25 |
| Male | 0.38 | 0.56 | 0.75 | 0.78 | 0.63 |
| Total | 0.66 | 0.81 | 1.07 | 1.15 | 0.94 |
| HIT | |||||
| Female | 1.52 | 1.92 | 4.01 | 9.41 | 4.41 |
| Male | 0.58 | 1.99 | 5.24 | 12.43 | 5.22 |
| Total | 1.03 | 1.96 | 4.63 | 10.90 | 4.82 |
*Does not include pregnancy-related events.
†Any major venous thrombosis: VTE, CVT, portal vein thrombosis, hepatic vein thrombosis/Budd-Chiari syndrome, thrombophlebitis migrans, embolism or thrombosis of vena cava (inferior), embolism or thrombosis of renal vein or mesenteric thrombosis.
CVT, cerebral venous thrombosis; DVT, deep vein thrombosis; HIT, heparin-induced thrombocytopenia; HUS, haemolytic-uremic syndrome; ITP, immune thrombocytopenic purpura; PE, pulmonary embolism; VTE, venous thromboembolism.